NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Nxstage Medical, Inc.

350 Merrimack Street
Lawrence, MA 01843
United States
978-687-4700
http://www.nxstage.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees3,800

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey H. BurbankFounder, CEO & Director1.14M237.8k1963
Mr. Joseph E. Turk Jr.Pres608.44k249.1k1968
Mr. Matthew W. TowseSr. VP, CFO & Treasurer483.72k117.15k1963
Ms. Winifred L. SwanSr. VP, Gen. Counsel & Sec.468.77k99.53k1964
Dr. Allan J. Collins M.D., FACPHead of Scientific Advisory Board and Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

Corporate Governance

Nxstage Medical, Inc.’s ISS Governance QualityScore as of June 1, 2018 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.